Tumor Cell-mediated Induction of the Stromal Factor Stromelysin-3 Requires Heterotypic Cell Contact-dependent Activation of Specific Protein Kinase C Isoforms

This publication has 60 references indexed in Scilit:

• Inhibitors of Protein Kinase C (PKC) Prevent Activated Transcription
  Published by Elsevier ,2004
• Science on the Rise in Developing Countries
  PLoS Biology, 2004
• Active stromelysin‐3 (MMP‐11) increases MCF‐7 survival in three‐dimensional Matrigel culture via activation of p42/p44 MAP‐kinase
  International Journal of Cancer, 2003
• Subtype- and species-specific knockdown of PKC using short interfering RNA (siRNA)
  Biochemical and Biophysical Research Communications, 2002
• Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector
  Oncogene, 2002
• New functions for the matrix metalloproteinases in cancer progression
  Nature Reviews Cancer, 2002
• Demonstration in vivo that stromelysin-3 functions through its proteolytic activity
  Oncogene, 2000
• In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy
  The Journal of cell biology, 1998
• Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3
  Journal of Biological Chemistry, 1997
• A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
  Nature, 1990